Structural Basis for Apoptosis Inhibition by Epstein-Barr Virus BHRF1

1. GalluzziL

BrennerC

MorselliE

TouatZ

KroemerG

2008 Viral control of mitochondrial apoptosis. PLoS Pathog 4 e1000018

2. CuconatiA

WhiteE

2002 Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection. Genes and Development 16 2465 2478

3. CuconatiA

DegenhardtK

SundararajanR

AnschelA

WhiteE

2002 Bak and Bax function to limit adenovirus replication through apoptosis induction. J Virol 76 4547 4558

4. MarchiniA

TomkinsonB

CohenJI

KieffE

1991 BHRF1, the Epstein-Barr virus gene with homology to Bc12, is dispensable for B-lymphocyte transformation and virus replication. J Virol 65 5991 6000

5. HendersonS

HuenD

RoweM

DawsonC

JohnsonG

1993 Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci U S A 90 8479 8483

6. Thorley-LawsonDA

GrossA

2004 Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350 1328 1337

7. TsujimotoY

CossmanJ

JaffeE

CroceCM

1985 Involvement of the bcl-2 gene in human follicular lymphoma. Science 228 1440 1443

8. AltmannM

HammerschmidtW

2005 Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis. PLoS Biol 3 e404

9. KellyGL

LongHM

StylianouJ

ThomasWA

LeeseA

2009 An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link. PLoS Pathog 5 e1000341

10. TaubR

KirschI

MortonC

LenoirG

SwanD

1982 Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A 79 7837 7841

11. AdamsJM

HarrisAW

PinkertCA

CorcoranLM

AlexanderWS

1985 The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318 533 538

12. MagrathI

1990 The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 55 133 270

13. StrasserA

HarrisAW

BathML

CoryS

1990 Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348 331 333

14. BeverlyLJ

VarmusHE

2009 MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family. Oncogene 28 1274 1279

15. KellyG

BellA

RickinsonA

2002 Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat Med 8 1098 1104

16. GreenDR

KroemerG

2004 The pathophysiology of mitochondrial cell death. Science 305 626 629

17. CrossJR

PostigoA

BlightK

DownwardJ

2008 Viral pro-survival proteins block separate stages in Bax activation but changes in mitochondrial ultrastructure still occur. Cell Death Differ 15 997 1008

18. FlanaganAM

LetaiA

2008 BH3 domains define selective inhibitory interactions with BHRF-1 and KSHV BCL-2. Cell Death Differ 15 580 588

19. UrenRT

DewsonG

ChenL

CoyneSC

HuangDC

2007 Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak. J Cell Biol 177 277 287

20. ChenL

WillisSN

WeiA

SmithBJ

FletcherJI

2005 Differential targeting of pro-survival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Molecular Cell 17 393 403

21. WillisSN

FletcherJI

KaufmannT

van DelftMF

ChenL

2007 Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315 856 859

22. CartronPF

GallenneT

BougrasG

GautierF

ManeroF

2004 The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA. Molecular Cell 16 807 818

23. KuwanaT

Bouchier-HayesL

ChipukJE

BonzonC

SullivanBA

2005 BH3 Domains of BH3-Only Proteins Differentially Regulate Bax-Mediated Mitochondrial Membrane Permeabilization Both Directly and Indirectly. Molecular Cell 17 525 535

24. LetaiA

BassikM

WalenskyL

SorcinelliM

WeilerS

2002 Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2 183 192

25. OltvaiZN

MillimanCL

KorsmeyerSJ

1993 Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 609 619

26. WhiteE

SabbatiniP

DebbasM

WoldWSM

KusherDI

1992 The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α. Molecular and Cellular Biology 12 2570 2580

27. KvansakulM

van DelftMF

LeeEF

GulbisJM

FairlieWD

2007 A structural viral mimic of prosurvival bcl-2: a pivotal role for sequestering proapoptotic bax and bak. Molecular Cell 25 933 942

28. JabbourAM

PuryerMA

YuJY

LithgowT

RiffkinCD

2006 Human Bcl-2 cannot directly inhibit the Caenorhabditis elegans Apaf-1 homologue CED-4, but can interact with EGL-1. J Cell Sci 119 2572 2582

29. HsuYT

YouleRJ

1997 Nonionic detergents induce dimerization among members of the Bcl-2 family. J Biol Chem 272 13829 13834

30. TaoW

KurschnerC

MorganJI

1997 Modulation of cell death in yeast by the Bcl-2 family of proteins. J Biol Chem 272 15547 15552

31. DesbienAL

KapplerJW

MarrackP

2009 The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim. Proc Natl Acad Sci U S A 106 5663 5668

32. TheodorakisP

D'Sa-EipperC

SubramanianT

ChinnaduraiG

1996 Unmasking of a proliferation-restraining activity of the anti-apoptosis protein EBV BHRF1. Oncogene 12 1707 1713

33. BouilletP

MetcalfD

HuangDCS

TarlintonDM

KayTWH

1999 Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286 1735 1738

34. EgleA

HarrisAW

BouilletP

CoryS

2004 Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc Natl Acad Sci U S A 101 6164 6169

35. HuangQ

PetrosAM

VirginHW

FesikSW

OlejniczakET

2003 Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2. Journal of Molecular Biology 332 1123 1130

36. LiuX

DaiS

ZhuY

MarrackP

KapplerJW

2003 The structure of a Bcl-xL/Bim fragment complex: Implications for Bim function. Immunity 19 341 352

37. MuchmoreSW

SattlerM

LiangH

MeadowsRP

HarlanJE

1996 X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381 335 341

38. CzabotarPE

LeeEF

van DelftMF

DayCL

SmithBJ

2007 Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc Natl Acad Sci U S A 104 6217 6222

39. LeeEF

SadowskyJD

SmithBJ

CzabotarPE

Peterson-KaufmanKJ

2009 High-resolution structural characterization of a helical alpha/beta-peptide foldamer bound to the anti-apoptotic protein Bcl-xL. Angew Chem Int Ed Engl 48 4318 4322

40. OltersdorfT

ElmoreSW

ShoemakerAR

ArmstrongRC

AugeriDJ

2005 An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435 677 681

41. van DelftMF

WeiAH

MasonKD

VandenbergCJ

ChenL

2006 The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 10 389 399

42. SchmittCA

RosenthalCT

LoweSW

2000 Genetic analysis of chemoresistance in primary murine lymphomas. Nat Med 6 1029 1035

43. LiuMY

ShihYY

LiLY

ChouSP

SheenTS

2000 Expression of the Epstein-Barr virus BHRF1 gene, a homologue of Bcl-2, in nasopharyngeal carcinoma tissue. J Med Virol 61 241 250

44. OudejansJJ

van den BruleAJ

JiwaNM

de BruinPC

OssenkoppeleGJ

1995 BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes. Blood 86 1893 1902

45. KvansakulM

YangH

FairlieWD

CzabotarPE

FischerSF

2008 Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ 15 1564 1571

46. EmsleyP

CowtanK

2004 Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60 2126 2132

47. MurshudovGN

VaginAA

DodsonEJ

1997 Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53 240 255

48. StoroniLC

McCoyAJ

ReadRJ

2004 Likelihood-enhanced fast rotation functions. Acta Crystallogr D Biol Crystallogr 60 432 438

49. O'ConnorL

StrasserA

O'ReillyLA

HausmannG

AdamsJM

1998 Bim: a novel member of the Bcl-2 family that promotes apoptosis. Embo J 17 384 395

50. MoriishiK

HuangDC

CoryS

AdamsJM

1999 Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1. Proc Natl Acad Sci U S A 96 9683 9688

51. FletcherJI

MeusburgerS

HawkinsCJ

RiglarDT

LeeEF

2008 Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax. Proc Natl Acad Sci U S A 105 18081 18087

52. HuangDC

O'ReillyLA

StrasserA

CoryS

1997 The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. Embo J 16 4628 4638

53. DewsonG

SnowdenRT

AlmondJB

DyerMJ

CohenGM

2003 Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells. Oncogene 22 2643 2654

54. Wilson-AnnanJ

O'ReillyLA

CrawfordSA

HausmannG

BeaumontJG

2003 Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity. J Cell Biol 162 877 887

55. HawkinsCJ

WangSL

HayBA

1999 A cloning method to identify caspases and their regulators in yeast: identification of Drosophila IAP1 as an inhibitor of the Drosophila caspase DCP-1. Proc Natl Acad Sci U S A 96 2885 2890

56. ZhaJ

HaradaH

OsipovK

JockelJ

WaksmanG

1997 BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity. J Biol Chem 272 24101 24104